Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E22.80 EPS (ttm)2.59 Insider Own0.06% Shs Outstand1.59B Perf Week2.04%
Market Cap94.07B Forward P/E15.12 EPS next Y3.91 Insider Trans20.72% Shs Float1.57B Perf Month7.26%
Income4.17B PEG2.47 EPS next Q0.77 Inst Own80.70% Short Float5.91% Perf Quarter11.64%
Sales19.26B P/S4.88 EPS this Y-23.10% Inst Trans15.91% Short Ratio8.03 Perf Half Y12.30%
Book/sh3.27 P/B18.06 EPS next Y23.84% ROA14.50% Target Price67.38 Perf Year28.81%
Cash/sh6.43 P/C9.18 EPS next 5Y9.23% ROE92.70% 52W Range42.58 - 60.02 Perf YTD14.59%
Dividend1.68 P/FCF42.26 EPS past 5Y0.00% ROI23.20% 52W High-1.60% Beta-
Dividend %2.84% Quick Ratio2.70 Sales past 5Y- Gross Margin76.40% 52W Low38.70% ATR0.85
Employees25000 Current Ratio2.80 Sales Q/Q5.00% Oper. Margin31.20% RSI (14)70.85 Volatility1.60% 1.40%
OptionableYes Debt/Eq2.83 EPS Q/Q3.00% Profit Margin21.70% Rel Volume1.21 Prev Close59.45
ShortableYes LT Debt/Eq2.77 EarningsOct 23 BMO Payout61.80% Avg Volume11.57M Price59.06
Recom1.80 SMA204.40% SMA507.63% SMA20013.49% Volume13,940,099 Change-0.66%
28-Jul-14Upgrade UBS Neutral → Buy $57 → $67
24-Jun-14Reiterated Argus Buy $59 → $65
06-Jan-14Reiterated UBS Neutral $46 → $56
29-Oct-13Reiterated Argus Buy $52 → $59
12-Aug-13Initiated Argus Buy $52
15-May-13Reiterated R. F. Lafferty Buy $47.90 → $61
29-Apr-13Reiterated Barclays Equal Weight $41 → $44
15-Apr-13Reiterated Barclays Equal Weight $37 → $41
19-Sep-14 02:30PM  AbbVie (ABBV) Declares 42c Quarterly Dividend at TheStreet
02:08PM  AbbVie Declares Quarterly Dividend PR Newswire
18-Sep-14 06:14AM  AbbVie call buyers back for more optionMONSTER
17-Sep-14 06:51PM  [$$] FDA Panel Recommends More Study on Testosterone Drugs at The Wall Street Journal
04:58PM  FDA panel backs limiting use of testosterone replacement drugs Reuters
12:52PM  Video: Gilead Stock Falls On These Drug Setbacks at Investor's Business Daily
12:52PM  Gilead Stock Is Falling On These Drug Setbacks at Investor's Business Daily
16-Sep-14 03:46PM  AbbVie Sued by Pension Fund Over $54.5 Billion Shire Deal at Bloomberg
01:57PM  Gilead Up As Analyst Lifts Sovaldi Q3 Estimate at Investor's Business Daily
11:36AM  Video: Valeant, Allergan Settle Suit, Allow Shareholder Vote at Investor's Business Daily
11:36AM  Valeant, Allergan Settle Suit, Allow Shareholder Vote at Investor's Business Daily
07:26AM  EU mergers and takeovers (Sept 16) Reuters
15-Sep-14 04:50PM  Biogen/AbbVie Report Positive Data on MS Drug Zinbryta Zacks
09:26AM  Shire eating disorder drug gets U.S. priority review Reuters
07:13AM  Hynes Keller & Hernandez, LLC Announces Investigation of World Acceptance Corp., PTC, Inc. and AbbVie Inc. PR Newswire
12-Sep-14 05:36PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
04:05PM  AbbVie's Humira Positive in Phase III Skin Disease Study Zacks
07:30AM  Detailed Results from Biogen Idec and AbbVies Pivotal Phase 3 Decide Study Further Define the Efficacy and Safety Profile of ZINBRYTA (Daclizumab High-Yield Process) Business Wire
06:45AM  AbbVie draws short-term calls optionMONSTER
11-Sep-14 04:15PM  Seattle Genetics-Genmab Expand Deal for Antibody Platform Zacks
07:59AM  The Zacks Analyst Blog Highlights: AbbVie, Infinity Pharmaceuticals, Keryx Biopharmaceuticals, Gilead and Amgen Zacks
03:00AM  AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA┬« (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease PR Newswire
10-Sep-14 02:05PM  Top U.S. Senate Democrats unveil earnings stripping plan Reuters
10:17AM  Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval Zacks
04:17AM  S&P: Inversions Could Lead to Credit Downgrades at The Wall Street Journal
09-Sep-14 02:21PM  [$$] Federal Trade Commission Sues AbbVie, Other Drug Companies at The Wall Street Journal
11:11AM  [$$] Federal Trade Commission Sues AbbVie, Other Drug Companies at The Wall Street Journal
01:43AM  [$$] Federal Trade Commission Sues AbbVie, Other Drug Companies at The Wall Street Journal
01:02AM  [$$] Federal Trade Commission Sues AbbVie, Other Drug Companies at The Wall Street Journal
12:20AM  [$$] Federal Trade Commission Sues AbbVie, Other Drug Companies at The Wall Street Journal
08-Sep-14 11:21PM  [$$] Federal Trade Commission Sues AbbVie, Other Drug Companies at The Wall Street Journal
08:25PM  [$$] Federal Trade Commission Sues AbbVie, Other Drug Companies at The Wall Street Journal
05:50PM  [video] Inversion crackdown all talk, no action? at CNBC
05:02PM  FTC Sues Drug Makers Over Pay-To-Delay Deals at The Wall Street Journal
04:44PM  FTC Sues Drug Makers Over Pay-To-Delay Deals at The Wall Street Journal
04:20PM  [$$] FTC Sues AbbVie, Other Drug Companies at The Wall Street Journal
04:02PM  AbbVie, Teva broke law in AndroGel "pay for delay" deal, U.S. says Reuters
03:52PM  [$$] FTC Sues AbbVie, Other Drug Companies at The Wall Street Journal
03:52PM  Federal Trade Commission Sues AbbVie, Other Drug Companies The Wall Street Journal
02:53PM  FTC sues AbbVie, Teva over generic AndroGel AP
02:04PM  AbbVie, Teva Sued by FTC Over Delay in Generic AndroGel at Bloomberg
01:41PM  [$$] FTC Sues AbbVie, Other Drug Companies at The Wall Street Journal
01:02PM  Pharmacyclics Price Target Cut On Higher Spending at Investor's Business Daily
12:44PM  US FTC says AbbVie, Teva broke law in reaching AndroGel agreement Reuters
09:42AM  [video] Faber Report: Jack Lew speaks out at CNBC
08:47AM  Story Stocks from Briefing.com Briefing.com
08:07AM  Story Stocks from Briefing.com Briefing.com
07:11AM  Story Stocks from Briefing.com Briefing.com
06:45AM  Story Stocks from Briefing.com Briefing.com
05:16AM  Calls bet AbbVie will resume rally optionMONSTER
03:24AM  Tax inversion makes a tempting M&A bet at Financial Times
07-Sep-14 02:08PM  Biggest tax inverters 'have $21bn offshore' at Financial Times
05-Sep-14 03:15PM  Why Gilead Is Falling On Drugs For Developing Nations at Investor's Business Daily
01:00PM  Story Stocks from Briefing.com Briefing.com
11:09AM  Story Stocks from Briefing.com Briefing.com
09:59AM  Story Stocks from Briefing.com Briefing.com
08:18AM  The Zacks Analyst Blog Highlights: Google, AbbVie, Abbott Laboratories, Apple and Intel Zacks
08:00AM  AbbVie to Present at Morgan Stanley Global Healthcare Conference PR Newswire
07:54AM  Story Stocks from Briefing.com Briefing.com
07:13AM  Story Stocks from Briefing.com Briefing.com
06:32AM  Story Stocks from Briefing.com Briefing.com
04-Sep-14 04:10PM  Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? Zacks
03:38PM  Google's Calico in $500M Joint Venture with AbbVie Zacks
02:50PM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
01:02PM  Story Stocks from Briefing.com Briefing.com
12:49PM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
12:41PM  Story Stocks from Briefing.com Briefing.com
12:18PM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
11:13AM  Story Stocks from Briefing.com Briefing.com
09:41AM  Story Stocks from Briefing.com Briefing.com
07:50AM  Story Stocks from Briefing.com Briefing.com
07:13AM  Story Stocks from Briefing.com Briefing.com
06:30AM  Story Stocks from Briefing.com Briefing.com
02:02AM  Burger King's 'Not About The Taxes' Whopper? Playboy For The Articles at Forbes
12:10AM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
03-Sep-14 11:13PM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
09:49PM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
09:18PM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
08:46PM  [$$] Google, AbbVie Announce Research Partnership at The Wall Street Journal
07:11PM  [$$] Google, AbbVie In Research Pact at The Wall Street Journal
06:36PM  Infinity, AbbVie team on drug Investor's Business Daily
06:11PM  Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership Zacks
05:34PM  PVH shares rise on earnings beat at MarketWatch
04:55PM  ABBVIE INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online
04:05PM  Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance PR Newswire
03:49PM  [video] Google, AbbVie Launch Partnership, and More at MarketWatch
03:30PM  Google's Calico, AbbVie forge deal against diseases of aging Reuters
02:46PM  Google's Calico Joins AbbVie In 'Pivotal' Partnership To Develop Anti-Aging Drugs at Forbes
02:23PM  Google's Calico, AbbVie forge deal against diseases of aging Reuters
01:50PM  Google, AbbVie announce research partnership at MarketWatch
01:44PM  [$$] Google, AbbVie In Research Pact at The Wall Street Journal
01:35PM  [video] Infinity Pharma teams up with AbbVie for cancer drug at CNBC
01:23PM  [$$] Google, AbbVie In Research Pact at The Wall Street Journal
01:19PM  Google Healthcare Startup Calico Partners With Abbvie at TheStreet
01:03PM  AbbVie, Calico forge deal against age-related diseases Reuters
01:00PM  Google Joins AbbVie in $1.5 Billion Aging Disease Effort at Bloomberg
01:00PM  AbbVie And Calico Announce A Novel Collaboration To Accelerate The Discovery, Development And Commercialization Of New Therapies PR Newswire
10:45AM  Credit Suisses 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014 24/7 Wall St.
09:08AM  Stock Futures Up And Climbing; Baidu Heads China Stock Rally at Investor's Business Daily
08:51AM  Toll Brothers builds up profits; Netflix nabs another TV series; Concur for sale? Hot Stock Minute
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; Synthroid to treat hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; Norvir , a protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. It has a strategic collaboration with Infinity Pharmaceuticals, Inc.; and a research and development collaboration with California Life Sciences LLC. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013, AbbVie Inc. operates independently of Abbott Laboratories.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GONZALEZ RICHARD AChairman of the Board and CEOMar 04Sale51.204,799245,706395,403Mar 04 05:13 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCMar 03Sale50.034,143207,284273,585Mar 04 05:18 PM
SALEKI-GERHARDT AZITASVP, OperationsMar 03Sale50.252,443122,76085,828Mar 04 05:17 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 03Sale50.223,948198,259180,068Mar 04 05:12 PM
ALBAN CARLOSEVP, Commercial OperationsMar 03Sale50.092,882144,356205,138Mar 04 05:10 PM
HURWICH THOMAS A.VP, ControllerFeb 18Option Exercise44.939,138410,57061,016Feb 19 05:33 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCFeb 18Option Exercise43.218,928385,779256,224Feb 19 05:35 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 18Sale51.2346523,82283,913Feb 19 05:35 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 10Option Exercise45.061,46666,05865,856Feb 12 04:49 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 05Sale47.8468732,86664,390Feb 07 05:08 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 05Sale47.781,46069,76385,470Feb 07 05:08 PM